Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)

HKD 51.05

(-1.64%)

Market Cap (In HKD)

28.35 Billion

Revenue (In HKD)

7.82 Billion

Net Income (In HKD)

2.26 Billion

Avg. Volume

318.46 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
37.6-93.8
PE
-
EPS
-
Beta Value
0.159
ISIN
CNE100004Z06
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Hao Hong Ph.D.
Employee Count
-
Website
https://www.asymchem.com.cn
Ipo Date
2021-12-10
Details
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.